cbdMD lowers Series B Conversion Price to $0.60

cbdMD amended its Series B Convertible Preferred Stock certificate to reduce the conversion price from an unspecified previous rate to $0.60, effective September 2, 2026. This change enhances the attractiveness for existing holders or prospective investors converting preferred shares into common equity.